Division of Gynecologic Oncology
Division Chief
The Division of Gynecologic Oncology plays an integral part in Columbia University Irving Medical Center’s academic and clinical community. Our physicians work with researchers at the Herbert Irving Comprehensive Cancer Center to translate advances in research into clinical practice and to investigate new treatments to improve patients’ outcomes. We collaborate to deliver the best patient care, to educate future leaders in the field, and to advance research to improve patients’ health and quality of life.
Patient Care
Patients benefit from a multidisciplinary approach to prevention, diagnosis, treatment, and follow up. Our gynecologic oncologists consult with leading researchers and specialists in related fields: pathology, radiation oncology, genetics, and reconstructive surgery.
Our physicians are members of the Gynecologic Oncology Group, a multi-institutional clinical research group funded by the National Cancer Institute and participants in other notable cooperative trial groups. This association provides our patients with opportunities to participate in innovative clinical trials involving the latest, most promising chemotherapeutic treatments, including novel, targeted biologic agents.
Education
The division offers a three-year Gynecologic Oncology Fellowship. Physicians in the division also train medical students and residents. Columbia’s Vagelos College of Physicians & Surgeons is the only major medical school in New York City designated by the National Cancer Institute as a Comprehensive Cancer Center and has maintained this highest level of designation for nearly 40 years.
Research
Our division participates in nationally-recognized, interdisciplinary programs supported by the Herbert Irving Comprehensive Cancer Center to advance research and training to discover the best approaches for cancer prevention, diagnosis, and treatment. Research includes ovarian cancer, chemotherapy resistance, clinical trials for gynecological cancers and Human Papillomavirus (HPV), investigating the development of cervical dysplasia or cancer. Ongoing clinical research focuses on the epidemiologic evaluation of gynecologic cancers.
Our physicians are members of the Gynecologic Oncology Group (GOG), a multi-institutional clinical research group funded by the NCI and participants in other notable cooperative trial groups. This association provides our patients with opportunities to participate in innovative clinical trials involving the latest, most promising chemotherapeutic treatments, including novel, targeted biologic agents.
Read more about research in the Division of Gynecologic Oncology
